| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 57,14 | 57,20 | 05.10. | |
| 57,18 | 57,24 | 05.10. |
Novonesis increases its full year 2026 organic sales growth outlook from 5-7% to now 7-8% based on a stronger performance so far in the year and the expectations for the rest of the year. Following the stronger sales growth outlook, the adjusted EBITDA margin is now expected to be at the higher end of the 37-38% range.
The H1 2026 announcement will be announced on August 19, 2026.
Publication of inside information pursuant to Market Abuse Regulation, Article 17.
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Novonesis (Novozymes A/S): Transactions under Novonesis' share buyback program | ||
| Do | Novonesis Expands Dairy Cultures Capacity Amid Rising Demand | ||
| Do | Novonesis (Novozymes A/S): Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities | Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities The acquisition adds advanced yeast-breeding expertise with a proven track record in bioethanol and broader potential... ► Artikel lesen | |
| 28.09. | Novonesis celebrates major expansion of West Allis production facility, strengthening North American dairy innovation and manufacturing | WEST ALLIS, Wis., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Novonesis, a global leader in biosolutions, announced the completion of a major expansion at its West Allis, Wisconsin production facility. The... ► Artikel lesen | |
| 28.09. | Novonesis (Novozymes A/S): Transactions under Novonesis' share buyback program |
